UPDATE 1-Novartis raises 2018 sales outlook as Entresto, Cosentyx accelerate
October 18, 2018 at 01:48 AM EDT
Swiss drugmaker Novartis raised its full-year sales outlook, citing growing revenue from its Cosentyx psoriasis and arthritis drug as well as the performance of its heart failure medicine Entresto, whose third-quarter sales more than doubled.
